Zurich, Switzerland

Reinhard Dummer

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Reinhard Dummer: Innovator in Cancer Treatment

Introduction

Reinhard Dummer is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of cancer treatment through his innovative research and patents. With a total of two patents to his name, Dummer is recognized for his work in developing therapies that enhance the effectiveness of cancer treatments.

Latest Patents

Dummer's latest patents focus on groundbreaking methods for treating solid cancers. One of his patents involves a combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) alongside immune checkpoint blockers. This invention aims to improve treatment outcomes for patients suffering from various forms of cancer. His second patent addresses the use of GDF-15 as a diagnostic marker to predict the clinical outcomes of patients undergoing treatment with immune checkpoint blockers. This method provides valuable insights into the likelihood of treatment response and survival rates for cancer patients.

Career Highlights

Reinhard Dummer is affiliated with Julius-Maximilians-Universität Würzburg, where he continues to advance his research in oncology. His work has garnered attention for its potential to revolutionize cancer treatment protocols and improve patient care.

Collaborations

Dummer collaborates with esteemed colleagues, including Jörg Wischhusen and Markus Haake, who contribute to his research endeavors. Their combined expertise enhances the development of innovative solutions in cancer therapy.

Conclusion

Reinhard Dummer's contributions to cancer treatment through his patents and research are noteworthy. His innovative approaches have the potential to significantly impact the field of oncology and improve the lives of many patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…